CLINICAL TRIALS PROFILE FOR FALLBACK SOLO
✉ Email this page to a colleague
All Clinical Trials for FALLBACK SOLO
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00664677 ↗ | Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia | Terminated | Erimos Pharmaceuticals | Phase 1 | 2007-08-01 | This study is designed to determine the safety, maximum tolerated dose,dose limiting toxicity of Terameprocol(EM-1421)and determine the pharmacokinetics (clearance from the blood)of Terameprocol(EM-1421)given as intravenous infusion three times a week in patients with leukemia. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for FALLBACK SOLO
Condition Name
Condition MeSH
| Condition MeSH for FALLBACK SOLO | |
| Intervention | Trials |
| Leukemia, Myeloid | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Myelodysplastic Syndromes | 1 |
| [disabled in preview] | 1 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for FALLBACK SOLO
Trials by Country
Clinical Trial Progress for FALLBACK SOLO
Clinical Trial Phase
Clinical Trial Sponsors for FALLBACK SOLO
Sponsor Name
